- All sections
- A - Human necessities
- A61M - Devices for introducing media into, or onto, the body; devices for transducing body media or for taking media from the body; devices for producing or ending sleep or stupor
- A61M 60/31 - Medical purposes thereof other than the enhancement of the cardiac output for enhancement of in vivo organ perfusion, e.g. retroperfusion
Patent holdings for IPC class A61M 60/31
Total number of patents in this class: 24
10-year publication summary
|
0
|
0
|
0
|
0
|
1
|
2
|
5
|
5
|
6
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| 3R Life Sciences Corporation | 23 |
3 |
| Glaukos Corporation | 183 |
2 |
| Wake Forest University Health Sciences | 707 |
2 |
| The Geneva Foundation | 4 |
2 |
| Certus Critical Care, Inc. | 17 |
2 |
| California Institute of Technology | 3884 |
1 |
| Edwards Lifesciences Corporation | 4141 |
1 |
| Huntington Medical Research Institutes | 27 |
1 |
| Johannes Kepler Universität Linz | 26 |
1 |
| Universitat Basel | 266 |
1 |
| Neurescue ApS | 18 |
1 |
| Nirvamed, Inc. | 7 |
1 |
| Vascular Perfusion Solutions, Inc. | 16 |
1 |
| Griesmühle Kleinkraftwerk GmbH | 4 |
1 |
| Triphasic Cardiac Pump Pty Ltd | 5 |
1 |
| Vestlandets Innovasjonsselskap AS (vis) | 9 |
1 |
| Artio Medical, Inc. | 63 |
1 |
| Polimed Research Sp. z o.o. | 1 |
1 |
| Other owners | 0 |